Filing Details
- Accession Number:
- 0000950170-24-132735
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:05:04
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-03 16:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Revvity Inc. | RVTY | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684136 | R. Prahlad Singh | 77 4Th Avenue Waltham MA 02451-7567 | Please See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 18,365 | $81.29 | 108,560 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 15,088 | $116.13 | 93,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 3,277 | $116.63 | 90,195 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2024-12-02 | 18,365 | $0.00 | 18,365 | $81.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-01-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 37,163 | Indirect | By Singh Family Trust of 2021 |
Footnotes
- The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 1, 2024.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.48 to $116.48. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.49 to $116.80. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.
Billionaire Hedge Funds
